Ignite Creation Date:
2024-05-05 @ 5:27 PM
Last Modification Date:
2024-10-26 @ 9:31 AM
Study NCT ID:
NCT00453063
Status:
COMPLETED
Last Update Posted:
2022-02-09
First Post:
2007-03-26
Brief Title:
Placebo-Controlled Study of Mometasone Furoate Nasal Spray MFNS 200 mcg Once Daily QD in the Treatment of Seasonal Allergic Rhinitis Study P05067COMPLETED
Sponsor:
Organon and Co
Organization:
Organon and Co
Study Overview
Official Title:
Placebo-Controlled Study of Mometasone Furoate Nasal Spray MFNS 200 mcg QD in the Treatment of Seasonal Allergic Rhinitis
Status:
COMPLETED
Status Verified Date:
2022-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study is designed to assess the effectiveness of mometasone furoate nasal spay MFNS once daily QD compared with placebo in subjects with seasonal allergic rhinitis SAR in reducing the total nasal symptom score and the total ocular symptom score
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None